Developing assay development tools to make screening less PAINS-full

Time: To be announced
To be announced


Triaging the output from a screening campaign can be a long and difficult process. Experienced drug hunters often share tales of healthy hit lists slowly (or not so slowly) evaporating upon progressing through a cascade of orthogonal and de-selection assays. Worse still, tales of compounds producing consistent activity throughout the screening process which, following significant investment of resources, turn out to be exhibiting some difficult to diagnose assay or target interference behaviour. To try and minimise these issues BioAscent has created a library of compounds with known mechanisms of assay/target interference activity and a set of common salts and synthesis contaminants that we use during assay development to interrogate the sensitivity of assays to problem compounds. This talk will detail the changing use of this set and how it has impacted upon how we run projects.

To view the video assoicated with this lecture click here

Hosted By


The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Web Site Find us on Facebook Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG,, Labhoo Ltd 2003-2022